Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
37.14
-1.74 (-4.48%)
At close: Jul 15, 2025, 4:00 PM
37.25
+0.11 (0.30%)
After-hours: Jul 15, 2025, 4:44 PM EDT
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $2.17 billion as of July 15, 2025. Its market cap has increased by 0.68% in one year.
Market Cap
2.17B
Enterprise Value
1.55B
1-Year Change
0.68%
Ranking
Category
Stock Price
$37.14
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $2.17B, an increase of 168.36%. That is a compound annual growth rate of 63.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 2.27B | -11.96% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |